TomoTherapy to Enhance Remote Service and Diagnostics Capabilities
Radiation Therapy Innovator to Deploy Questra IDM Application Suite™
MADISON, Wis. (Business Wire EON/PRWEB ) October 1, 2008 --
TomoTherapy Incorporated
(NASDAQ: TOMO), maker of the Hi·Art®
treatment system for advanced radiation therapy, today announced plans
to enhance the remote service and diagnostics capabilities of its
industry-leading customer support program.
In late 2008, TomoTherapy will pilot the Questra IDM (Intelligent Device
Management) Application Suite, an auto-intelligent remote support
solution from Questra Corporation.
Phase I integration of this capability will provide TomoTherapy with the
ability to remotely update Hi·Art
system software and receive product performance information over a
secure Internet connection to enhance overall user experience. In
subsequent phases of implementation, the Questra-based solution is
expected to offer Hi·Art users remote
planning, plan review and quality assurance capabilities.
For two consecutive quarters, TomoTherapy has topped MD Buyline’s
user satisfaction rankings for radiation therapy manufacturers.
According to Rich Springer, TomoTherapy’s vice
president of customer support, the partnership with Questra reinforces
TomoTherapy’s commitment to continuous
improvement.
“Our customers expect the best in both
treatment quality and customer service from TomoTherapy. Questra’s
device management solution will help us continue to deliver on these
expectations. In addition to optimizing Hi·Art
system uptime across our growing installed base, we expect to also
realize a new level of operational efficiency.”
Emil Wang, Questra CEO, added: “We are
delighted to be working with TomoTherapy as they take their customer
service to the next level. Innovative companies, like TomoTherapy, are
turning to remote, preemptive service as a means to deliver greater
value to their customers."
About Questra Corporation
Questra is leading the development and marketing of IDM solutions.
Equipment manufacturers use the Questra IDM Application Suite, which
proactively monitors and manages remote intelligent devices, to provide
superior yet cost-effective support to their customers. Agfa Graphics,
General Electric, Scientific Applications International Corporation
(SAIC), and Waters, among other Fortune 1000 companies, have chosen
Questra software as part of their corporate strategies to advance from
reactive to proactive equipment service and support. For more
information, visit www.questra.com.
About TomoTherapy Incorporated
TomoTherapy Incorporated has developed, markets and sells the TomoTherapy®
Hi·Art®
treatment system, an advanced radiation therapy system for the treatment
of a wide variety of cancers. The Hi·Art
treatment system combines integrated CT imaging with conformal radiation
therapy to deliver sophisticated radiation treatments with speed and
precision while reducing radiation exposure to surrounding healthy
tissue. The company’s stock is traded on the
NASDAQ Global Select Market under the symbol TOMO. To learn more about
TomoTherapy, please visit TomoTherapy.com.
Forward-Looking Statements
Statements in this release regarding future products, events,
expectations and other similar matters, including but not limited to
statements using the terms “plans”,
“will”, “can”
or “is expected to”
constitute forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Such forward-looking
statements contained in this press release are subject to risks and
uncertainties that could cause actual results to differ materially from
those anticipated, including but not limited to factors such as our
ability to gain customer acceptance, ability to complete development in
a timely manner, ability to protect intellectual property, risks of
interruption due to events beyond the company’s
control, and the other risks listed from time to time in TomoTherapy’s
filings with the U.S. Securities and Exchange Commission, which by this
reference are incorporated herein. These forward-looking statements
represent TomoTherapy’s judgments as of the
date of this press release. TomoTherapy assumes no obligation to update
or revise the forward-looking statements in this release because of new
information, future events or otherwise.
©2008 TomoTherapy Incorporated. All rights
reserved. TomoTherapy, the TomoTherapy logo and Hi·Art
are among trademarks, service marks or registered trademarks of
TomoTherapy Incorporated.
See the original story at: http://eon.businesswire.com/releases/questra_idm/application_suite/prweb1414574.htm
Post Comment: Trackback URL: http://www.prweb.com/pingpr.php/Q3Jhcy1aZXRhLUhhbGYtTG92ZS1IYWxmLVNpbmctWmVybw==
Bookmark -
Del.icio.us |
Furl It |
Technorati |
Ask |
MyWeb |
Propeller |
Live Bookmarks |
Newsvine |
TailRank |
Reddit |
Slashdot |
Digg |
Stumbleupon |
Google Bookmarks |
Sphere |
Blink It |
Spurl
|